Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-28 @ 2:01 PM
Study NCT ID:
NCT06199466
Status:
TERMINATED
Last Update Posted:
2025-12-08
First Post:
2023-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2023-12-29
First Submit QC Date:
None
Study First Post Date:
2024-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED